{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:58:21Z","timestamp":1780491501996,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jhep.2023.10.032","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T08:53:56Z","timestamp":1699001636000},"page":"e89-e91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["MASLD screening and diagnostic algorithms are interchangeable with existing NAFLD literature"],"prefix":"10.1016","volume":"80","author":[{"given":"Umang","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-4921","authenticated-orcid":false,"given":"Sagnik","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-2664","authenticated-orcid":false,"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-437X","authenticated-orcid":false,"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.10.032_bib1","article-title":"A multi\u2013society Delphi consensus statement on new fatty liver disease nomenclature","volume":"0","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.032_bib2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2021.09.002","article-title":"NAFLD vs. MAFLD - it is not the name but the disease that decides the outcome in fatty liver","volume":"76","author":"De","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.032_bib3","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD","volume":"0","author":"De","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.032_bib4","article-title":"Transitioning from NAFLD to MAFLD and MASLD: consistent prevalence and risk factors in a Chinese cohort","volume":"0","author":"Yang","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.032_bib5","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"0","author":"Song","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.032_bib6","first-page":"0","article-title":"The influence of different combinations of cardiometabolic risk factors on the prevalence of MASLD and risk of advanced fibrosis deserves attention","author":"Yang","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.032_bib7","article-title":"Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD","volume":"0","author":"Ratziu","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.032_bib8","article-title":"Changing from NAFLD through\u00a0MAFLD to MASLD: similar prevalence and risk factors in a large Brazilian cohort","volume":"0","author":"Perazzo","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.032_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-023-08085-y","article-title":"Poor performance of non-invasive tests\u00a0for advanced fibrosis in nonalcoholic fatty liver disease: a multicentric\u00a0asian study","author":"Arora","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2023.10.032_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823052327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823052327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T22:12:25Z","timestamp":1739571145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823052327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0168827823052327"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.10.032","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MASLD screening and diagnostic algorithms are interchangeable with existing NAFLD literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}